Ligand validation:4NV5

U10: UBIQUINONE-10

U10 is a Ligand Of Interest in 4NV5 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4NV5_U10_A_501	5%	30%	0.382	0.873	1.65	1.3	2	8	1	0	52%	0.5238
4NV5_U10_B_501	2%	30%	0.438	0.835	1.59	1.33	2	5	4	0	52%	0.5238
3KP9_U10_A_501	11%	11%	0.282	0.889	2.72	1.73	10	12	15	0	52%	0.5238
4NV2_U10_A_501	5%	29%	0.386	0.89	1.64	1.32	2	6	2	0	52%	0.5238
4NV6_U10_A_501	0%	13%	0.347	0.33	2.72	1.45	11	8	2	0	52%	0.5238
2BOZ_U10_M_1313	59%	23%	0.119	0.945	1.92	1.46	4	10	2	0	76%	0.7619
3ZUM_U10_M_1308	58%	9%	0.116	0.939	2.76	1.89	13	13	0	0	76%	0.7619
3ZUW_U10_M_1313	58%	10%	0.115	0.937	2.69	1.87	12	13	1	0	76%	0.7619
2GNU_U10_M_1305	55%	10%	0.111	0.931	2.57	1.9	11	16	1	0	71%	0.7143
2UWU_U10_M_1313	53%	12%	0.118	0.921	2.62	1.62	11	11	0	0	76%	0.7619

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.